27 related articles for article (PubMed ID: 17977659)
1. Tobacco smoking and MRI/MRS brain abnormalities compared to nonsmokers.
Domino EF
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1778-81. PubMed ID: 18817837
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization.
Szolnoki Z; Kondacs A; Mandi Y; Somogyvari F
J Mol Neurosci; 2007; 33(2):173-9. PubMed ID: 17917076
[TBL] [Abstract][Full Text] [Related]
3. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease.
Dhaenens CM; Van Brussel E; Schraen-Maschke S; Pasquier F; Delacourte A; Sablonnière B
Neurosci Lett; 2004 Sep; 368(3):290-2. PubMed ID: 15364413
[TBL] [Abstract][Full Text] [Related]
4. Gene-environmental effects behind leukoaraiosis: a silent genetic variant of the kinesin protein can be activated in a subject with poorly controlled long-lasting hypertension.
Szolnoki Z; Kondacs A; Mandi Y; Somogyvari F
Clin Biochem; 2009 May; 42(7-8):630-3. PubMed ID: 19046961
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the genetic variants of kinesin motor protein in ischemic stroke.
Szolnoki Z; Serly J; Kondacs A; Mandi Y; Somogyvari F
J Stroke Cerebrovasc Dis; 2009; 18(5):360-2. PubMed ID: 19717019
[TBL] [Abstract][Full Text] [Related]
6. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.
Andersson ME; Sjölander A; Andreasen N; Minthon L; Hansson O; Bogdanovic N; Jern C; Jood K; Wallin A; Blennow K; Zetterberg H
Int J Mol Med; 2007 Aug; 20(2):233-9. PubMed ID: 17611642
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the roles of the A185C and C406T kinesin light-chain 1 variants in the development of leukoaraiosis.
Szolnoki Z; Kondacs A; Mandi Y; Somogyvari F
Neurosci Lett; 2007 Dec; 429(2-3):101-4. PubMed ID: 17977659
[TBL] [Abstract][Full Text] [Related]
8. Reduced noncovalent connections in leukoaraiosis.
Szolnoki Z
Expert Rev Neurother; 2008 Feb; 8(2):205-13. PubMed ID: 18271708
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis).
Szolnoki Z
Neuromolecular Med; 2007; 9(1):21-33. PubMed ID: 17114822
[TBL] [Abstract][Full Text] [Related]
10. [Cognitive impairment associated to leukoaraiosis: its pathophysiology, clinical manifestations and treatment].
Jiménez I; Agulla J; Pouso M; Sabucedo M; Rodríguez-Yáñez M; Sobrino T; Brea D; Blanco M; Leira R; Castillo J
Rev Neurol; 2008 Nov 16-30; 47(10):536-44. PubMed ID: 19012258
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variants of the mitochondrial trafficking system and mitochondrial uncoupling proteins affect the development of two slowly developing demyelinating disorders, leukoaraiosis and multiple sclerosis.
Szolnoki Z
Curr Med Chem; 2010; 17(30):3583-90. PubMed ID: 20738244
[TBL] [Abstract][Full Text] [Related]
12. Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.
Lin Q; Huang WQ; Tzeng CM
Rev Neurosci; 2015; 26(3):343-58. PubMed ID: 25781674
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
